EAU 2013 - Programme Book - YouMed

1106 The German mRCC registry – aims and results after the first 1000 patients
P.J. Goebell, L. Müller, K. Blumenstengel, A. Hübner, A. Lück, M. Vogt, N. Marschner (Erlangen, Leer,
Eisenach, Rostock, Freiburg, Germany)
* 1107 Outcomes of patients with non clear cell renal cell carcinoma treated with targeted therapy and
prognostication using the International mRCC Database Consortium Criteria
N. Kroeger, W. Xie, J-L. Lee, G.A. Bjarnason, J.J. Knox, M.J. Mackenzie, L. Wood, S. Srinivas,
U.N. Vaishamayan, S.Y. Rha, S.K. Pal, T. Yuasa, F. Donskov, N. Agarwal, C.K. Kollmannsberger, M.H. Tan,
S.A. North, B.I. Rini, T.K. Choueiri, D.Y.C. Heng (Calgary, Toronto, Halifax, Vancouver, Edmonton, Canada;
Boston, Stanford, Detroit, Utah, Cleveland, United States of America; Asan, Seoul, Duarte, South Korea;
London, United Kingdom; Ariake, Tokyo, Japan; Århus, Denmark; Singapore, Singapore)
* 1108 Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma
T. Minami, T. Minami, N. Shimizu, Y. Yamamoto, M. De Velasco, T. Hayashi, H. Tsuji, M. Nozawa,
K. Yoshimura, T. Ishii, H. Uemura (Osaka-Sayama, Japan)
EAU Milan 2013
315
Monday